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ABSTRACT 
Non-alcoholic fatty liver disease (NAFLD) is seen in 30-50% of type 2 diabetics and 80-90% of obese 
individuals. NAFLD is the result of hepatic insulin resistance causing an imbalance between lipogenesis 
and lipolysis. NAFLD is commonly treated by caloric restriction; however, the influence of continued 
high-fructose intake on NAFLD during weight loss remains unclear. The purpose of this study was to 
determine the lipogenic effects of high-fructose consumption on NAFLD during weight loss in obese mice. 
Male C57BL/6 mice were fed either a low-fat (LFD; 10% kcal fat) or high-fat (60% kcal fat) with 20% 
fructose solution (HFD+HF) for 8-weeks. Following 8-weeks, HFD+HF were randomly assigned to either 
LFD or LFD+HF to induce weight loss for 6-weeks. After 6-weeks, plasma was assayed for total 
cholesterol, triglyceride, glucose and HOMA-IR. Total lipid, triglyceride and cholesterol levels were 
quantified in hepatic tissues. An ANOVA was used to identify significant (P<0.05) differences between 
groups. HFD+HF caused obesity, insulin resistance and hyperlipidemia, as well as NAFLD (Table 1). 
Following weight loss, the LFD+HF HOMA-IR was similar to LFD mice; however, plasma triglyceride 
levels remained elevated. Although hepatic mass and percent total lipid were reduced following weight 
loss, hepatic triglyceride levels in the mice switched to LFD and LFD+HF were 2.2- and 3.0-fold greater, 
respectively than that found in the LFD control mice. These data suggest that during weight loss high 
fructose consumption did not impair insulin resistance. Although no difference was observed between 
either weight loss group for hepatic lipid metabolism and plasma cholesterol; however, 
hypertriglyceridemia was observed with high-fructose consumption. 
 
Table 1. Whole body and hepatic metabolic characteristics following the 14-week diet intervention. 
Variables LFD (n=8) HFD+HF (n=8) HFF/LFD (n=8) HFF/LFD+HF (n=8) 
Body mass (g) 27.5 ± 0.6 44.0 ± 1.5* 31.0 ± 1.4*,† 26.4 ± 0.8† 
Liver mass (g) 1.2 ± 0.1 2.1 ± 0.2* 1.5 ± 0.1† 1.3 ± 0.1† 
Triglyceride (mg/dL) 103.8 ± 5.9 142.3 ± 15.0* 165.4 ± 27.0† 81.7 ± 15.8*,†,‡ 
Cholesterol (mg/dL) 131.3 ± 6.4 193.2 ± 10.9* 118.5 ± 8.5 168.3 ± 12.3*,‡ 
Glucose (mg/dL) 158.2 ± 24.3 241.9 ± 32.2* 127.9 ± 9.5† 124.6 ± 6.9† 
Insulin (ng/mL) 0.6 ± 0.1 2.1 ± 0.9* 0.66 ± 0.17† 0.69 ± 0.36† 
HOMA-IR 5.5 ± 1.2 32.1 ± 7.5* 7.3 ± 2.6† 3.5 ± 1.9† 
Liver Tg (µg/mg tissue) 10.5 ± 1.6 69.4 ± 5.7* 23.0 ± 3.7*,† 31.0 ± 4.6*,† 
Liver Chol (µg/mg tissue) 10.4 ± 0.9 8.0 ± 0.6* 10.9 ± 0.6† 11.4 ± 1.0† 
Note. Data are presented as mean ± SEM. Low-fat diet (LFD); high-fat diet and 20% fructose solution 
(HFD+HF); switched from HFD+HF to LFD at 8-weeks (HFF/LFD); switched from HFD+HF to LFD+HF 
at 8-weeks (HFF/LFD+HF). *Significantly different than LFD; †Significantly different than HFD+HF; 
‡Significantly different than HFF/LFD. 
